Navigation Links
Eclipse TS 100F

ProductsEclipse TS 100F
Company Nikon
Item Eclipse TS 100F
Features Inquire
Description The new Eclipse TS-100 is an innovative and efficient inverted routine microscope. This high quality tool complements any research facility. Outstanding Optical Performance CFI60 optics offer brilliant, sharp images in all magnifications. Objectives deliver superb optical performance with high resolution and contrast, chromatic aberration free correction (CF), and top transmission rates. CFI60 optics also allow the use of multiple observation techniques such as brightfield, darkfield, DIC, epi-fluorescence, phase contrast.
Info Nikon
Customer Service: (800) 526-4566
Web site: http://www.nikon.com

Related medicine products :

1. Eclipse E400
2. Eclipse TS100
3. Eclipse E200
4. Eclipse TS100F
5. Eclipse TE2000
6. Eclipse TS100/TS100F
7. Eclipse TS 100
8. Eclipse TE2000E
9. Eclipse TE2000S
10. Eclipse TE2000U
11. Eclipse TE2000E2
TAG: Eclipse
Spurling-Kerrison (Colclough) Laminectomie Rongeur. 15 cm - 6, thick footplate, large handle, 40 up-cutting, jaws 3 mm wide.
Kerrison (Micro) Laminectomie Rongeur, with ejector. 18 cm - 7 1/8, with thick footplate, small handle, 90 up-cutting, jaws 2 mm wide.
...ment Set offers maximum distraction with minimal n...y the Tangent Posterior Impacted Instrument Set ar...reproduce the technique. Set offers 9 different di...istraction. A variety of sizes of round scrapers, ...
Regulates physiological flow within normal ranges of Intraventricular Pressure (IVP) in the supine, sitting or standing position.
Medicine Products:
(Date:10/7/2008)...a Youth in Houston and San ...Carlson Hotels Worldwide and the,American Red Cros...ity bags,to children displaced by Hurricane Ike in...ctivity book, colored pencils, stickers, sunglasse...i-bin/prnh/20081007/AQTU541 ), "We wanted to prov...
(Date:10/7/2008)... -- Majesco Entertainment,Company (Nasdaq: COOL )...ss,market, today announced that Jillian Michaels, ...led to ship on October 21st for Wii(TM). The game ...fitness trainer --- Jillian,Michaels, the strength...series "The Biggest Loser" --- with the Wii(TM) sy...
(Date:10/7/2008)...Call/ -- Stallergenes S.A.,today announced that th...atalent for the promotion and distribution in Euro...eloped and co-manufactured by Catalent and,The Med...e pre-filled with adrenaline, which,will be availa..., in an,autoinjector device. The Medical House has...
(Date:10/7/2008)... Medical Devices Inc.,(CleveMed) announced it has ...unding from the National Institute on Aging to dev...r programming in deep brain,stimulation (DBS) proc...ollaborating with clinicians at the Center for Neu...dation, a world renowned, pioneering DBS surgery,c...
Breaking Medicine News(10 mins):Health News:Carlson Hotels Worldwide Partners With the American Red Cross in Texas to Provide Relief for Children Affected by Hurricane Ike 2Health News:Majesco Entertainment and Interactive Game Group Announce 'Jillian Michaels' Fitness Ultimatum 2009' Ships to Stores October 21st 2Health News:Majesco Entertainment and Interactive Game Group Announce 'Jillian Michaels' Fitness Ultimatum 2009' Ships to Stores October 21st 3Health News:Stallergenes Partners With Catalent and the Medical House for Commercialization of Adrenaline Autoinjector in Europe 2Health News:CleveMed Receives $1.23 Million in NIH Funding to Develop a System to Augment Deep Brain Stimulation Programming in Parkinson's Disease 2
...ing out of control, 'in'? A new report by the Ame...sy with reports of college girls and their wild (s... has revealed that breaking out of control and goi...ing fun in life. Three out of four women seem to g...
...art is under pressure as it is asked to improve it...llary Rodham Clinton who has had deep// ties with ...linton served on Wal-Mart's board of directors for...er time on the board of Wal-Mart was a memorable o...
...'s joy and relief at Norfolk as surgeons at the No...ven the green signal to make available the breast/... for her-2 gene. "We made the business case and ... groups, and the primary care trusts have backed t...
...esearch by the British Heart Foundation says that ... to fall a victim to heart disease than people// o...type 2 diabetes as compared to 3 percent of the ge...ate concern are the high rates of untreated diabet...
Other Medicine News:
(Date:10/7/2008)...n once-daily significantly,improved the symptoms o...ewswire-FirstCall/ -- Shire plc (LSE: SHP,Nasdaq:...mpany, today,announced that a study published in t...hiatry found once-daily VYVANSE significantly impr...D) symptoms in adults within,the first week of tre...
(Date:10/7/2008)...ligen Therapeutics Inc.,today announced that in vi...dates were presented at the XXII International Com...ighlighted the candidates, efficacy in,several ani...se highlighted presentations, as well as several i...l the deep expertise and expanding,knowledge base ...
(Date:10/7/2008)...trolled Phase II Study Shows Statisticall...N VIEW, California, October 7 /- BN,I...se II data from the,therapeutic prostate cancer va...d as part of the recently entered partnership with...The results from the Phase II prospective randomiz...
(Date:10/7/2008)...for Use on the GeneXpert(R) ...wswire-FirstCall/ -- Cepheid (Nasdaq:,CPHD) today ...European CE,IVD Mark product under the European Di...e test delivers rapid detection of vanA and/or van...ancomycin-resistant,enterococci (VRE) -- one of th...
Breaking Medicine Technology:Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 3Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 4Best Practice Database 3A Complimentary Excerpt of Designing Effective Brand Teams 3A Structure Governance Performance and Operations 5408 1Best Practice Database 3A Complimentary Excerpt of Designing Effective Brand Teams 3A Structure Governance Performance and Operations 5408 2President Musevenis Visit Protested by HIV AIDS Experts 5405 1President Musevenis Visit Protested by HIV AIDS Experts 5405 2VIDEO from Medialink and EcoQuest 3A New Technology Reduces Exposure to MRSA Staph 5402 1Meredith Martin Addy Named Chair of AIPLAs Amicus Committee 1676 1Meredith Martin Addy Named Chair of AIPLAs Amicus Committee 1676 2
... clinical development program of first-in-class CB...ight reduction and,avoid image as life-style drug ... Intelligence,firm La Merie S.L. reported today th...nist Acomplia (rimonabant) has at least,five compe... more,in earlier phases of R&D. While Acomplia...
...pany Outlines Development Plans - , ,OTTAWA, Canad...LPX), a biopharmaceutical company specializing in ...ty Lipoprotein (HDL), often,called “good cho...ase I/II Clinical Trial of its lead product, CRD5....ipidemia and heart,disease. , ,Results showed, to ...
Other Medicine Technology:Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 2Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 3Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5 2Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5 3